Selected Abstracts of the 2nd Congress of joint European Neonatal Societies (jENS 2017); Venice (Italy); October 31-November 4, 2017; Session "Neonatal Hematology and Bilirubin"

Abstract

Selected Abstracts of the 2^nd Congress of joint European Neonatal Societies (jENS 2017); Venice (Italy); October 31-November 4, 2017

58^th ESPR Annual Meeting, 7^th International Congress of UENPS, 3^rd International Congress of EFCNI

ORGANIZING INSTITUTIONS
European Society for Paediatric Research (ESPR), European Society for Neonatology (ESN), Union of European Neonatal & Perinatal Societies (UENPS), European Foundation for the Care of Newborn Infants (EFCNI)

ORGANIZING COMMITTEE
Luc Zimmermann (President of ESPR), Morten Breindahl (President of ESN), Manuel Sánchez Luna (President of UENPS), Silke Mader (Chairwoman of the Executive Board and Co-Founder of EFCNI)

SCIENTIFIC COMMITTEE
Virgilio P. Carnielli (Congress President Chair), Pierre Gressens (Past Scientific President), Umberto Simeoni, Manon Benders, Neil Marlow, Ola D. Saugstad, Petra Hüppi, Agnes van den Hoogen

Session "Neonatal Hematology and Bilirubin"

ABS 1. PROLONGED JAUNDICE SCREENING: FULL BLOOD COUNT (FBC) OR NO FBC! • N. Storring, R. Doherty, V. Ponnusamy

ABS 2. EFFECT OF PROBIOTIC SUPPLEMENTATION ON BREAST MILK JAUNDICE • N. Koksal, O. Bagcı, H. Ozkan, I. Varal, P. Dogan

ABS 3. LABORATORY FINDINGS, DIAGNOSIS AND TREATMENT OF THE NEWBORN ADMITTED DUE TO HEMATEMESIS OR BLOODY STOOL IN 11 YEARS • I. Hokuto, Y. Ito, T. Mori, S. Komachi

ABS 4. AN UNUSUAL CAUSE OF CYANOSIS: SEVERE METHEMOGLOBINEMIA IN A PRETERM INFANT WITH SEPSIS • F. Bakar, M. Berber

ABS 5. THE INFLUENCE OF INTRAUTERINE TRANSFUSION ON THE OUTCOMES OF NEWBORNS WITH SEVERE HEMOLYTIC DISEASE • E. Balashova, O. Bystrykh, T. Fedorova, O. Ionov, A. Kirtbaya, D. Sharafutdinova, V. Zubkov, D. Degtyarev, O. Horoshkeeva, N. Fedorova, N. Tetruashvili, K. Kostukov, N. Karetnikova

ABS 6. PATCHED SKIN BILIRUBIN ASSAY TO MONITOR EXTREMELY PRETERM NEONATES UNDERGOING PHOTOTHERAPY • D. De Luca, V. Dell’Orto

ABS 7. A PRETERM MODEL OF HYPERBILIRUBINEMIA-INDUCED CEREBELLAR DYSFUNCTION • C.F. Bearer, M. He, J.F. Watchko, J.M. Simard, N. Tang

ABS 8. PHYSIOLOGIC FREE BILIRUBIN REDISTRIBUTES L1 CELL ADHESION MOLECULE (L1) IN LIPID RAFTS • N. Tang, M. He, J.F. Watchko, C.F. Bearer

ABS 9. RETICULOCYTE HEMOGLOBIN CONTENT AS AN EARLY INDEX OF IRON DEFICIENCY IN NEONATAL PERIOD • P. Karagianni, E. Chatzitoliou, V. Antari, M. Lithoxopoulou, G. Mitsiakos, C. Tsakalidis, A. Kioumi, V. Soubasi

ABS 10. PREDICTION OF MAJOR BLEEDING IN EXTREMELY LOW BIRTH WEIGHT INFANTS (< 1,000 g) BY SEQUENTIAL COAGULATION MONITORING • M. Thanhaeuser, C. Binder, M. Kornsteiner-Krenn, U. Derhaschnig, B. Jilma, A. Repa, A. Berger, N. Haiden

ABS 11. IV FLUID SUPPLEMENTATION IN SEVERE NEONATAL HYPERBILIRUBINEMIA: YES OR NO • M.T. Saleh, S. El Doory, S. Saleh, Mel. Halik

ABS 12. RIGHT SUBCLAVIAN ARTERY THROMBOSIS. A CASE REPORT • G. Uclés, T. Fuentes, R. Villarino, M. González-Valcárcel, A. Martínez

ABS 13. RISK FACTORS FOR PORTAL VENOUS THROMBOSIS IN NEWBORNS: A RET­RO­SPECTIVE STUDY • A. Zanin, M. Colella, C. Farnoux, S. Soudee, M. Leport, R. Stern, O. Bequet, M. Alison, V. Biran, O. Baud

ABS 14. COMPARISONS BETWEEN TRANSCUTANEOUS BILIRUBINOMETRY, POINT-OF-CARE WHOLE BLOOD BILIRUBIN AND TOTAL PLASMA BILIRUBIN MEASUREMENT IN NEONATES • K. Palmkvist Kaijser, C. Backman Johansson, K. Hemse Nojd, C. Bemgard, K. Kjellson, G. Marchini

ABS 15. RELATIONSHIP BETWEEN PLASMA LEVELS OF BILIRUBIN AND OXIDANT/ANTIOXIDANT STATUS IN THE EARLY NEONATAL PERIOD IN PRETERM INFANTS • G.I. Zoutkamp, K. Suzuki, C.H.P. van den Akker

ABS 16. RELATIONSHIP BETWEEN LEUKOCYTES AND PLATELETS AND PREMATURE RETINOPATHY • V. Filip, C. Lazar

ABS 17. CONGENITAL HEPATOCELLULAR CARCI­NO­MA ASSOCIATED WITH NEONATAL HEMO­CHROMATOSIS • P. Francalanci, C. Grimaldi, M.C. Saffioti, R. Angelico, R. Boldrini, F. Callea

ABS 18. INVESTIGATION OF THE RELATIONSHIP BETWEEN UMBILICAL CORD BLOOD RMI LEVEL AND PERINATAL EVENTS • Z.E. Erdem Dursun, N. Guzoglu, D. Aliefendioglu

ABS 19. OUTCOME OF BABIES WITH SERUM BILIRUBIN LEVEL OF GREATER THAN 400 MICROMOL/L • R. Prasad, S.V. Rasiah

ABS 20. AN AUDIT OF USE OF EMERGENCY 0 NEGATIVE BLOOD IN NEONATES FOR EMERGENCY BLOOD TRANSFUSIONS AND EXCHANGE TRANSFUSIONS • P. Tormey, D. Sweetman, J. Quigley, J. Fitzgerald

ABS 21. THE COAGULATION SCREEN AS A BIO­MARKER OF NEONATAL ENCEPHALOPATHY OUT­COMES • D. Sweetman, J. Murphy, E.J. Molloy